Progression of a Group of Patients Suffering From Emotional Dysregulation But Heterogeneous in Terms of Diagnosis, Benefiting From the DBT Group Programme.
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Aug 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a specific therapy called Dialectical Behaviour Therapy (DBT) can help people who struggle with managing their emotions. Emotional dysregulation can be a challenge for individuals with various mental health conditions, such as borderline personality disorder, bipolar disorder, addiction issues, eating disorders, and post-traumatic stress disorder (PTSD). The trial aims to see how effective a DBT group program is in teaching patients skills to better manage their emotions, improve their relationships, and cope with stress.
To participate in the trial, individuals must be between 18 and 65 years old, have emotional dysregulation, and be receiving care from specific mental health services in the Saint Etienne area. Participants will learn four key skills: mindfulness (being aware of the present moment), interpersonal skills (how to communicate and relate to others), emotional regulation (managing feelings), and distress tolerance (handling difficult situations). It’s important to note that people with certain conditions, like psychotic disorders or severe aggressive behaviors, will not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients affiliated to or entitled under a social security scheme
- • Patients aged 18 to 65 suffering from emotional dysregulation and presenting one of the following clinical profiles: borderline disorder, bipolar disorder, addictive disorders, eating disorders, PTSD.
- • Follow-up by the Saint Etienne sector (mobile teams, psychological medical centre, intra-hospital services, full-time therapeutic reception centre and day hospitals).
- • DERS scale score \> 94.
- • Patient having received informed information about the study and having signed consent to participate in the study.
- Exclusion Criteria:
- • Psychotic disorders,
- • Melancholic depression,
- • Aggressive and hostile behaviour preventing group work,
- • Intellectual deficit,
- • Patient under guardianship.
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
St Etienne, Saint Priest En Jarez, France
Patients applied
Trial Officials
Yohann MASSE, nurse
Principal Investigator
CHU SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported